BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29706011)

  • 1. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
    Akobeng AK
    Acta Paediatr; 2018 Nov; 107(11):2019-2023. PubMed ID: 29706011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
    Saha A; Tighe MP; Batra A
    Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
    J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
    Kennedy NA; Clark A; Walkden A; Chang JC; Fascí-Spurio F; Muscat M; Gordon BW; Kingstone K; Satsangi J; Arnott ID; Lees CW
    J Crohns Colitis; 2015 Jan; 9(1):41-9. PubMed ID: 25135754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin in suspected paediatric inflammatory bowel disease.
    Degraeuwe PL; Beld MP; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AG
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):339-46. PubMed ID: 25373864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
    An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
    Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
    Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
    Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
    Fraga M; Godat S; Nydegger A; Moradpour D; Schoepfer AM
    Rev Med Suisse; 2012 Sep; 8(352):1669-70, 1672-3. PubMed ID: 22988727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
    McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
    BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
    Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.
    Heida A; Van de Vijver E; Muller Kobold A; van Rheenen P
    BMJ Open; 2017 May; 7(5):e015636. PubMed ID: 28554936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
    Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.